cbdMD, Inc. (NYSEAMERICAN:YCBD) Sees Significant Decrease in Short Interest

cbdMD, Inc. (NYSEAMERICAN:YCBD) saw a significant decline in short interest in the month of December. As of December 31st, there was short interest totaling 1,234,477 shares, a decline of 68.9% from the December 15th total of 3,970,725 shares. Approximately 12.5% of the company’s shares are sold short. Based on an average trading volume of 24,116,987 shares, the days-to-cover ratio is currently 0.1 days. Based on an average trading volume of 24,116,987 shares, the days-to-cover ratio is currently 0.1 days. Approximately 12.5% of the company’s shares are sold short.

Insiders Place Their Bets

In other cbdMD news, major shareholder Clark R. Crosnoe sold 550,701 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The stock was sold at an average price of $2.32, for a total value of $1,277,626.32. Following the completion of the sale, the insider owned 17,875 shares of the company’s stock, valued at approximately $41,470. This trade represents a 96.86% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 2.10% of the company’s stock.

Institutional Trading of cbdMD

A hedge fund recently raised its stake in cbdMD stock. Chapin Davis Inc. grew its stake in cbdMD, Inc. (NYSEAMERICAN:YCBD) by 62.5% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 118,626 shares of the company’s stock after purchasing an additional 45,626 shares during the period. Chapin Davis Inc. owned approximately 1.33% of cbdMD worth $106,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 7.18% of the company’s stock.

cbdMD Stock Performance

NYSEAMERICAN YCBD traded down $0.09 during trading on Tuesday, hitting $1.08. 625,457 shares of the company’s stock traded hands, compared to its average volume of 1,304,913. cbdMD has a 12-month low of $0.47 and a 12-month high of $6.54. The stock has a fifty day moving average of $0.97 and a two-hundred day moving average of $0.93.

About cbdMD

cbdMD, Inc (NYSEAMERICAN: YCBD) is a Charlotte, North Carolina–based producer and distributor of hemp-derived cannabidiol (CBD) products. Since its founding in 2018, the company has focused on developing a diverse portfolio of wellness offerings designed for human and pet use. Its product range includes tinctures, capsules, gummies, topicals, and pet-specific formulations, each developed to comply with U.S. Food and Drug Administration (FDA) guidelines for hemp-derived substances.

The company operates a vertically integrated business model, sourcing U.S.-grown hemp and overseeing manufacturing processes in cGMP-certified facilities.